← Back to directory

Tiago F. Outeiro

Researcher Next ID · RN-028406

Researcher · Medicine

German Center for Neurodegenerative Diseases

Bonn, Portugal

Not currently recruitingFunding unknown
Works count
528
Citation count
31,249
H-index
85
i10-index
293

Research interests

Medicine
Neuroscience
Parkinson's Disease Mechanisms and Treatments
Alzheimer's disease research and treatments
Genetic Neurodegenerative Diseases
Neurological disorders and treatments
Nuclear Receptors and Signaling

Publications

  • A biological classification of Parkinson's disease: the SynNeurGe research diagnostic criteria

    The Lancet Neurology · 2024 · 10.1016/s1474-4422(23)00404-0

  • α-Synuclein phosphorylation at serine 129 occurs after initial protein deposition and inhibits seeded fibril formation and toxicity

    Proceedings of the National Academy of Sciences · 2022 · 10.1073/pnas.2109617119

  • Dementia with Lewy bodies: an update and outlook

    Molecular Neurodegeneration · 2019 · 10.1186/s13024-019-0306-8

  • Small molecule inhibits α-synuclein aggregation, disrupts amyloid fibrils, and prevents degeneration of dopaminergic neurons

    Proceedings of the National Academy of Sciences · 2018 · 10.1073/pnas.1804198115

  • Glyoxal as an alternative fixative to formaldehyde in immunostaining and super‐resolution microscopy

    The EMBO Journal · 2017 · 10.15252/embj.201695709

  • α-synuclein interacts with PrPC to induce cognitive impairment through mGluR5 and NMDAR2B

    Nature Neuroscience · 2017 · 10.1038/nn.4648

  • The mechanism of sirtuin 2–mediated exacerbation of alpha-synuclein toxicity in models of Parkinson disease

    PLoS Biology · 2017 · 10.1371/journal.pbio.2000374

  • Glycation potentiates α-synuclein-associated neurodegeneration in synucleinopathies

    Brain · 2017 · 10.1093/brain/awx056

  • Emerging Role of Sirtuin 2 in the Regulation of Mammalian Metabolism

    Trends in Pharmacological Sciences · 2015 · 10.1016/j.tips.2015.08.001

  • Structure, function and toxicity of alpha‐synuclein: the Bermuda triangle in synucleinopathies

    Journal of Neurochemistry · 2015 · 10.1111/jnc.13249

  • Protein phosphorylation in neurodegeneration: friend or foe?

    Frontiers in Molecular Neuroscience · 2014 · 10.3389/fnmol.2014.00042

  • Autophagy modulates SNCA/α-synuclein release, thereby generating a hostile microenvironment

    Autophagy · 2014 · 10.4161/auto.36436

  • Systematic Comparison of the Effects of Alpha-synuclein Mutations on Its Oligomerization and Aggregation

    PLoS Genetics · 2014 · 10.1371/journal.pgen.1004741

  • SIRT1 and SIRT2: emerging targets in neurodegeneration

    EMBO Molecular Medicine · 2013 · 10.1002/emmm.201302451

  • Alpha-synuclein: from secretion to dysfunction and death

    Cell Death and Disease · 2012 · 10.1038/cddis.2012.94

  • Extracellular Alpha-Synuclein Oligomers Modulate Synaptic Transmission and Impair LTP Via NMDA-Receptor Activation

    Journal of Neuroscience · 2012 · 10.1523/jneurosci.0234-12.2012

  • α-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells

    Journal of Clinical Investigation · 2011 · https://doi.org/10.1172/jci43366

  • Convergence of miRNA Expression Profiling, α-Synuclein Interacton and GWAS in Parkinson's Disease

    PLoS ONE · 2011 · 10.1371/journal.pone.0025443

  • Formation of Toxic Oligomeric α-Synuclein Species in Living Cells

    PLoS ONE · 2008 · 10.1371/journal.pone.0001867

  • Direct quantification of CSF α-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration

    Experimental Neurology · 2008 · 10.1016/j.expneurol.2008.06.004

  • Sirtuin 2 Inhibitors Rescue α-Synuclein-Mediated Toxicity in Models of Parkinson's Disease

    Science · 2007 · https://doi.org/10.1126/science.1143780

  • Pharmacological promotion of inclusion formation: A therapeutic approach for Huntington’s and Parkinson’s diseases

    Proceedings of the National Academy of Sciences · 2006 · 10.1073/pnas.0511256103

  • Effects of Q/N-rich, polyQ, and non-polyQ amyloids on the de novo formation of the [ PSI + ] prion in yeast and aggregation of Sup35 in vitro

    Proceedings of the National Academy of Sciences · 2004 · 10.1073/pnas.0404968101

  • Yeast Genes That Enhance the Toxicity of a Mutant Huntingtin Fragment or α-Synuclein

    Science · 2003 · 10.1126/science.1090389

  • Yeast Cells Provide Insight into Alpha-Synuclein Biology and Pathobiology

    Science · 2003 · https://doi.org/10.1126/science.1090439

Current projects

    No projects listed.